These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1812353)

  • 21. [Clinical evaluation of the tolerability of gadodiamide, a new nonionic contrast agent in MRI of the central nervous system].
    Aslanian V; Lemaignen H; Bunouf P; Schiratti M; Lambrechts M; Lundby B; Borseth A; Svaland M
    J Radiol; 1995 Jul; 76(7):431-4. PubMed ID: 7473377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gd DTPA. Clinical efficacy.
    Runge VM; Schaible TF; Goldstein HA; Wood ML; Haughton VM; Maravilla KR; Weinstein MA; Price AC; Wolpert SM; Kaufman D
    Radiographics; 1988 Jan; 8(1):147-59. PubMed ID: 3353531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system: review of clinical use of contrast media.
    Runge VM; Muroff LR; Jinkins JR
    Top Magn Reson Imaging; 2001 Aug; 12(4):231-63. PubMed ID: 11687713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus.
    Miller DH; Buchanan N; Barker G; Morrissey SP; Kendall BE; Rudge P; Khamashta M; Hughes GR; McDonald WI
    J Neurol; 1992 Oct; 239(8):460-4. PubMed ID: 1447575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadolinium-DTPA enhanced gradient echo magnetic resonance scans in first episode of psychosis and chronic schizophrenic patients.
    Szymanski S; Ashtari M; Zito J; Degreef G; Bogerts B; Lieberman J
    Psychiatry Res; 1991 Nov; 40(3):203-7. PubMed ID: 1780393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.
    Nakamura T; Schörner W; Bittner RC; Felix R
    Neuroradiology; 1988; 30(6):481-6. PubMed ID: 3226534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging of intracranial tumors using gadolinium-DTPA. Initial experience with fast imaging.
    Niendorf HP; Felix R; Laniado M; Schörner W; Kornmesser W; Claussen C
    Acta Radiol Suppl; 1986; 369():561-3. PubMed ID: 2980558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paramagnetic enhancement of cerebral lesions with gadolinium-DTPA.
    Hesselink JR; Dunn WM; Healy ME; Hajek P; Baker L; Brahme FJ
    Acta Radiol Suppl; 1986; 369():558-60. PubMed ID: 2980556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
    Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gadolinium-DTPA-enhanced magnetic resonance imaging in intractable partial epilepsy.
    Cascino GD; Hirschorn KA; Jack CR; Sharbrough FW
    Neurology; 1989 Aug; 39(8):1115-8. PubMed ID: 2503770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine.
    Sze G; Brant-Zawadzki M; Haughton VM; Maravilla KR; McNamara MT; Kumar AJ; Aisen AM; Dreisbach JN; Bradley WG; Weinreb JC
    Radiology; 1991 Dec; 181(3):693-9. PubMed ID: 1947084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gd-DTPA enhancement in MR imaging of central pontine myelinolysis.
    Koch KJ; Smith RR
    AJNR Am J Neuroradiol; 1989; 10(5 Suppl):S58. PubMed ID: 2505569
    [No Abstract]   [Full Text] [Related]  

  • 36. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.
    Valk J; de Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI; Nauta JJ
    Acta Radiol; 1987; 28(6):659-65. PubMed ID: 2962597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
    Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
    Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress.
    Unger E; Needleman P; Cullis P; Tilcock C
    Invest Radiol; 1988 Dec; 23(12):928-32. PubMed ID: 3203995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetization transfer contrast in Gd-DTPA-enhanced imaging of brain tumors.
    Niemi P; Kurki T; Lundbom N; Kormano M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S248-9; discussion S253-4. PubMed ID: 1808140
    [No Abstract]   [Full Text] [Related]  

  • 40. Magnetic resonance imaging with gadolinium contrast agent in small deep (lacunar) cerebral infarcts.
    Regli L; Regli F; Maeder P; Bogousslavsky J
    Arch Neurol; 1993 Feb; 50(2):175-80. PubMed ID: 8431136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.